Clinical Trial Update: Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating discontinuation of cholinesterase inhibitors in severe Alzheimer's disease has completed. The update reports the outcomes of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• Aricept (Donepezil)
• Exelon (rivastigmine)
• Razadyne (Galantamine)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Alzheimer's Disease, Dementia | Phase 3 | Status: COMPLETED